Reviva Pharmaceuticals Holdings, Inc. (RVPH) stock
RVPHOTCPharmaceutical PreparationsFiscal year ends December 31
$0.45−0.02 (-4.36%)
Close on Oct 19, 2026Market cap $5.94MP/E –Yield –
Reviva Pharmaceuticals price to book ratio
The price-to-book ratio is market cap divided by shareholders' equity.
Reviva Pharmaceuticals's price to book ratio was 0.4× on Oct 19, 2026, against 51.7× a year earlier. Over the last 4 years it ranged from 0.3× to 83.6×, with a median of 4.8×.
Price to Book Ratio at the end of each year
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| 2026 | Oct 19, 2026 | 0.4× | −5.7 |
| 2025 | Dec 31, 2025 | 6.1× | −9.3 |
| 2024 | Apr 30, 2024 | 15.3× | −46.3 |
| 2023 | Jul 31, 2023 | 61.6× | +56.5 |
| 2022 | Dec 30, 2022 | 5.1× | +3.8 |
| 2021 | Dec 31, 2021 | 1.2× | −3.8 |
| 2020 | Dec 31, 2020 | 5.0× | – |
See a number that looks wrong?